potential indications for glp-1 receptor agonists keep expanding Diabetes vs GLP-1 for Weight Loss: What's Changing for Patients and Pharmacies? Indications for GLP-1/GIP RA Summary
Description
Some plans exclude weight loss medications altogether
The glucagon-like Peptide-1 analog exenatide increases blood glucose clearance, lactate clearance, and heart rate in comatose patients after out-of-hospital cardiac arrest
In the STEP 13 clinical trials conducted between 2018 and 2020, semaglutide was shown to significantly reduce inflammatory markers
Semaglutide for metabolic intervention and adipose loss to treat atrial fibrillation
Phentermine on the other hand has mild stimulant side effects
Its simply marketed under a different brand name
